Difficulty: Medium
Average Score: 94%
Practice
Tick the drug, inhibiting viral reverse transcriptase:
Correct answer
A
Rationale
In the context of safety pharmacology across the lifespan, understanding the mechanisms of antiviral drugs is crucial. The correct answer is A) Zidovudine, which inhibits viral reverse transcriptase, a key enzyme in the replication of HIV. Zidovudine belongs to the class of nucleoside reverse transcriptase inhibitors (NRTIs) and is commonly used in the treatment of HIV/AIDS.
Option B) Vidarabine is an antiviral medication used to treat herpes simplex and varicella-zoster viruses by inhibiting viral DNA polymerase, not reverse transcriptase. Option C) Rimantadine is an antiviral drug used to treat and prevent influenza A virus infections by inhibiting the viral uncoating process, not reverse transcriptase. Option D) Gancyclovir is used to treat cytomegalovirus (CMV) infections by inhibiting viral DNA polymerase, not reverse transcriptase.
Educationally, this question reinforces the importance of knowing specific drug mechanisms in the context of safety pharmacology. Understanding how different antiviral drugs work can guide healthcare professionals in selecting the most appropriate treatment for patients across different stages of life, considering factors like drug efficacy, safety, and potential interactions.
Option B) Vidarabine is an antiviral medication used to treat herpes simplex and varicella-zoster viruses by inhibiting viral DNA polymerase, not reverse transcriptase. Option C) Rimantadine is an antiviral drug used to treat and prevent influenza A virus infections by inhibiting the viral uncoating process, not reverse transcriptase. Option D) Gancyclovir is used to treat cytomegalovirus (CMV) infections by inhibiting viral DNA polymerase, not reverse transcriptase.
Educationally, this question reinforces the importance of knowing specific drug mechanisms in the context of safety pharmacology. Understanding how different antiviral drugs work can guide healthcare professionals in selecting the most appropriate treatment for patients across different stages of life, considering factors like drug efficacy, safety, and potential interactions.